Try our Advanced Search for more refined results

Sanofi Asks To Go Solo With Its EpiPen Fight Against Mylan

By Bonnie Eslinger (July 27, 2017, 10:51 PM EDT) -- Sanofi-Aventis US LLC on Thursday implored the Judicial Panel on Multidistrict Litigation to keep its anti-competition suit against EpiPen maker Mylan Inc. separate from putative purchaser class actions over pricing, saying its case is distinct and would be "significantly bogged down" by the others....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

Law Firms

Companies

Government Agencies

Judge Analytics

powered by Lex Machina®

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!